Lakewood-Amedex partners with PERI for Nu-3 phase 2 trial
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced it has entered into an agreement with Professional Education and Research Institute LLC to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
